GEN Genetic Engineering and Biotechnology News with John McCloskey.
Original article by Kathy Liszews – GEN
Diseases such as cancer often feature chromosomal breaks, rearrangements, and added or missing segments. Cytogenetic (that is, chromosomal) analyses can help clinicians improve their diagnostic capabilities, treatment decisions, and outcome assessments.
“Certain processes in the cytogenetics workflow, which for many years have been performed manually, are slow and labor intensive,” said John McCloskey, director of sales, North America, ADS Biotec. “There is an ongoing shift by many laboratories to adopt automation for workflow tasks that occur upstream of analysis and pathology review.
Click here to read more
For More Information:
ADS Biotec Inc.
Stavros Papadimitriou – Vice President of Marketing